mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
0.003 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.44 |
0.003 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.003 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |